{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:21:51Z","timestamp":1792815711381,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clinre.2025.102573","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T23:34:01Z","timestamp":1742081641000},"page":"102573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A prospective cohort study"],"prefix":"10.1016","volume":"49","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-guo","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3000-085X","authenticated-orcid":false,"given":"Li-ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clinre.2025.102573_bib0001","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102573_bib0002","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0003","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"10.1016\/j.clinre.2025.102573_bib0004","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.clinre.2025.102573_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2024.101172","article-title":"Evaluation of long-term benefits and cost-effectiveness of nation-wide colorectal cancer screening strategies in China in 2020\u20132060: a modelling analysis","volume":"51","author":"Lu","year":"2024","journal-title":"Lancet Regional Health - Western Pacific"},{"issue":"7","key":"10.1016\/j.clinre.2025.102573_bib0006","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"10.1016\/j.clinre.2025.102573_bib0007","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.clinre.2025.102573_bib0008","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2025.102573_bib0009","article-title":"Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.clinre.2025.102573_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156004","article-title":"Metabolic dysfunction-associated steatotic liver disease and its link to cancer","author":"Kalligeros","year":"2024","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.clinre.2025.102573_bib0011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2025.102573_bib0012","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/liv.15856","article-title":"Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults","volume":"44","author":"Song","year":"2024","journal-title":"Liver Int"},{"issue":"11\u201312","key":"10.1016\/j.clinre.2025.102573_bib0013","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/apt.18286","article-title":"Metabolic dysfunction-associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: a nationwide cohort study","volume":"60","author":"Park","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2025.102573_bib0014","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4143\/crt.2023.539","article-title":"Association between metabolically healthy status and risk of gastrointestinal cancer","volume":"56","author":"Cui","year":"2024","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.clinre.2025.102573_bib0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.ajkd.2023.08.016","article-title":"Association of stroke with metabolic dysfunction-associated fatty liver disease with and without CKD","volume":"83","author":"Li","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.clinre.2025.102573_bib0016","first-page":"955","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2025.102573_bib0017","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.tem.2024.02.012","article-title":"Evolving liver disease insights from NAFLD to MASLD","volume":"35","author":"Fan","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0018","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0019","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.21037\/hbsn-21-546","article-title":"Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China","volume":"12","author":"Yuan","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"10.1016\/j.clinre.2025.102573_bib0022","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.cgh.2020.05.009","article-title":"Associations between nonalcoholic fatty liver disease and cancers in a large cohort in China","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102573_bib0023","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clinre.2025.102573_bib0024","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2025.102573_bib0025","article-title":"Long-term outcomes and risk modifiers of MASLD between lean and non-lean populations","author":"Danpanichkul","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102573_bib0026","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: a cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.clinre.2025.102573_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102569","article-title":"Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: a comprehensive meta-analysis","volume":"49","author":"Nso","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102573_bib0028","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/liv.15763","article-title":"Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"44","author":"Souza","year":"2024","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2025.102573_bib0029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2025.102573_bib0030","first-page":"947","article-title":"Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update[J]","volume":"34","year":"2018","journal-title":"J Clin Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102573_bib0031","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cgh.2006.09.014","article-title":"Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers","volume":"4","author":"Limburg","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102573_bib0032","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/ijms20122922","article-title":"Obesity, insulin resistance, and colorectal cancer: could miRNA dysregulation play A role?","volume":"20","author":"Cirillo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"Supplement_1","key":"10.1016\/j.clinre.2025.102573_bib0033","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.2337\/dc25-S004","article-title":"4. Comprehensive medical Evaluation and Assessment of comorbidities: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.clinre.2025.102573_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","article-title":"Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial","volume":"22","author":"Sandsdal","year":"2023","journal-title":"Cardiovasc Diabetol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:31:59Z","timestamp":1746444719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2210740125000531"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102573","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102573","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102573"}}